Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Hamilton MP, Sugio T, Noordenbos T, Shi S, et al. N Engl J Med 2024;390:2047-2060.

Read + Share

Amedeo Smart

Independent Medical Education

Hamilton MP, Sugio T, Noordenbos T, Shi S, et al. Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. N Engl J Med 2024;390:2047-2060.
PMID: 38865660